Phase II single-arm study of brentuximab vedotin in Chinese patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large cell lymphoma

Song, YQ; Guo, Y; Huang, HQ; Li, W; Ke, XY; Feng, JF; Xu, W; Miao, H; Kinley, J; Song, G; Dai, Y; Wang, H; Zhu, J

Zhu, J (corresponding author), Beijing Canc Hosp, Fucheng Rd 52, Beijing 100142, Peoples R China.

EXPERT REVIEW OF HEMATOLOGY, 2021; 14 (9): 867

Abstract

Background: Relapsed/refractory (R/R) classical HL (cHL) and systemic anaplastic large-cell lymphoma (sALCL) treatment options are limited in China. T......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索